{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T20:55:12Z","timestamp":1676667312698},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1097\/01.jaa.0000456567.37724.e0","type":"journal-article","created":{"date-parts":[[2014,11,12]],"date-time":"2014-11-12T15:32:12Z","timestamp":1415806332000},"page":"10-17","source":"Crossref","is-referenced-by-count":2,"title":["Oral preexposure prophylaxis to prevent HIV infection"],"prefix":"10.1097","volume":"27","author":[{"given":"Jonathan","family":"Baker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin Michael","family":"O'Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"16","key":"R3-3-20210130","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.2013.280034","article-title":"Effect of risk-reduction counseling with rapid HIV testing on risk of acquiring sexually transmitted infections: the AWARE randomized clinical trial.","volume":"310","author":"Metsch","year":"2013","journal-title":"JAMA"},{"issue":"6","key":"R4-3-20210130","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/00006454-199506000-00012","article-title":"Zidovudine for the reduction of perinatal human immunodeficiency virus transmission: pediatric AIDS Clinical Trials Group Protocol 076results and treatment recommendations.","volume":"14","author":"Connor","year":"1995","journal-title":"Pediatr Infect Dis J"},{"issue":"RR-2","key":"R5-3-20210130","first-page":"1","article-title":"Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services.","volume":"54","author":"Smith","year":"2005","journal-title":"MMWR Recomm Rep"},{"issue":"6","key":"R6-3-20210130","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa1105243","article-title":"Prevention of HIV-1 infection with early antiretroviral therapy.","volume":"365","author":"Cohen","year":"2011","journal-title":"N Engl J Med"},{"issue":"12","key":"R7-3-20210130","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/01.JAA.0000437820.76526.41","article-title":"Stay current with options for HIV prevention.","volume":"26","author":"Baker","year":"2013","journal-title":"JAAPA"},{"issue":"27","key":"R8-3-20210130","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.","volume":"363","author":"Grant","year":"2010","journal-title":"N Engl J Med"},{"issue":"5","key":"R9-3-20210130","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJMoa1108524","article-title":"Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.","volume":"367","author":"Baeten","year":"2012","journal-title":"N Engl J Med"},{"issue":"5","key":"R10-3-20210130","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJMoa1110711","article-title":"Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.","volume":"367","author":"Thigpen","year":"2012","journal-title":"N Engl J Med"},{"issue":"9883","key":"R11-3-20210130","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","article-title":"Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.","volume":"381","author":"Choopanya","year":"2013","journal-title":"Lancet"},{"issue":"5","key":"R12-3-20210130","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1202614","article-title":"Preexposure prophylaxis for HIV infection among African women.","volume":"367","author":"Van Damme","year":"2012","journal-title":"N Engl J Med"},{"issue":"9","key":"R14-3-20210130","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S1473-3099(14)70847-3","article-title":"Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study.","volume":"14","author":"Grant","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"R15-3-20210130","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJM199807023390107","article-title":"Acute human immunodeficiency virus type 1 infection.","volume":"339","author":"Kahn","year":"1998","journal-title":"N Engl J Med"},{"issue":"8","key":"R16-3-20210130","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1128\/JCM.00119-09","article-title":"Assessment of the ability of a fourth-generation immunoassay for human immunodeficiency virus (HIV) antibody and p24 antigen to detect both acute and recent HIV infections in a high-risk setting.","volume":"47","author":"Pandori","year":"2009","journal-title":"J Clin Microbiol"},{"issue":"11","key":"R19-3-20210130","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1086\/644785","article-title":"Low bone mineral density, renal dysfunction, and fracture risk in HIV infection: a cross-sectional study.","volume":"200","author":"Calmy","year":"2009","journal-title":"J Infect Dis"},{"issue":"8","key":"R21-3-20210130","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1592\/phco.24.11.970.36141","article-title":"Effect of tenofovir disoproxil fumarate on the pharmacokinetics and pharmacodynamics of total, R-, and S-methadone.","volume":"24","author":"Smith","year":"2004","journal-title":"Pharmacotherapy"},{"issue":"23","key":"R22-3-20210130","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1056\/NEJMoa0802878","article-title":"Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.","volume":"359","author":"Marcellin","year":"2008","journal-title":"N Engl J Med"},{"issue":"5","key":"R23-3-20210130","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1086\/514750","article-title":"Chronic active hepatitis B exacerbations in human immunodeficiency virus-infected patients following development of resistance to or withdrawal of lamivudine.","volume":"28","author":"Bessesen","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"2","key":"R24-3-20210130","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1371\/journal.pmed.0050028","article-title":"Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir.","volume":"5","author":"Garcia-Lerma","year":"2008","journal-title":"PLoS Med"},{"issue":"4","key":"R25-3-20210130","doi-asserted-by":"crossref","first-page":"e18165","DOI":"10.1371\/journal.pone.0018165","article-title":"Factors influencing the emergence and spread of HIV drug resistance arising from rollout of antiretroviral pre-exposure prophylaxis (PrEP).","volume":"6","author":"Abbas","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"R26-3-20210130","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/infdis\/jit189","article-title":"Prophylactic efficacy of oral emtricitabine and tenofovir disoproxil fumarate combination therapy against a tenofovir-resistant simianhuman immunodeficiency virus containing the K65R mutation in macaques.","volume":"208","author":"Cong","year":"2013","journal-title":"J Infect Dis"},{"issue":"12","key":"R27-3-20210130","doi-asserted-by":"crossref","first-page":"e81355","DOI":"10.1371\/journal.pone.0081355","article-title":"Closing the gap: Increases in life expectancy among treated HIV-positive individuals in the United States and Canada.","volume":"8","author":"Samji","year":"2013","journal-title":"PloS One"},{"issue":"18","key":"R29-3-20210130","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1097\/QAD.0b013e328355713d","article-title":"Does ART prevent HIV transmission among MSM.","volume":"26","author":"Muessig","year":"2012","journal-title":"AIDS"},{"issue":"4","key":"R30-3-20210130","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/MLR.0b013e31815c31a7","article-title":"What does the value of modern medicine say about the 50,000 per quality-adjusted life-year decision rule.","volume":"46","author":"Braithwaite","year":"2008","journal-title":"Med Care"},{"issue":"6","key":"R31-3-20210130","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1086\/597095","article-title":"HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness.","volume":"48","author":"Paltiel","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"8","key":"R32-3-20210130","doi-asserted-by":"crossref","first-page":"541","DOI":"10.7326\/0003-4819-156-8-201204170-00001","article-title":"The cost-effectiveness of preexposure prophylaxis for HIV prevention in the United States in men who have sex with men.","volume":"156","author":"Juusola","year":"2012","journal-title":"Ann Intern Med"},{"issue":"14","key":"R33-3-20210130","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1097\/QAD.0b013e32830e00f5","article-title":"Modeling the impact of HIV chemoprophylaxis strategies among men who have sex with men in the United States: HIV infections prevented and cost-effectiveness.","volume":"22","author":"Desai","year":"2008","journal-title":"AIDS"},{"issue":"6","key":"R34-3-20210130","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/COH.0b013e3283582c8b","article-title":"Cost-effectiveness of pre-exposure prophylaxis for HIV: a review.","volume":"7","author":"Schackman","year":"2012","journal-title":"Curr Opin HIV AIDS"},{"issue":"5","key":"R35-3-20210130","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0001-4575(86)90012-6","article-title":"Beyond the concept of risk homeostasis: suggestions for research and application towards the prevention of accidents and lifestyle-related disease.","volume":"18","author":"Wilde","year":"1986","journal-title":"Accid Anal Prev"},{"issue":"9201","key":"R36-3-20210130","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0140-6736(99)09109-6","article-title":"Condoms and seat belts: the parallels and the lessons.","volume":"355","author":"Richens","year":"2000","journal-title":"Lancet"},{"issue":"12","key":"R37-3-20210130","doi-asserted-by":"crossref","first-page":"e81997","DOI":"10.1371\/journal.pone.0081997","article-title":"No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis.","volume":"8","author":"Marcus","year":"2013","journal-title":"PloS One"},{"issue":"2","key":"R38-3-20210130","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1089\/apc.2011.0283","article-title":"Sexual risk behaviors and acceptability of HIV pre-exposure prophylaxis among HIV-negative gay and bisexual men in serodiscordant relationships: a mixed methods study.","volume":"26","author":"Brooks","year":"2012","journal-title":"AIDS Patient Care STDS"},{"issue":"5","key":"R39-3-20210130","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/QAI.0b013e3181e19a54","article-title":"Preexposure prophylaxis and predicted condom use among high-risk men who have sex with men.","volume":"54","author":"Golub","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"R40-3-20210130","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/01720610-201212000-00014","article-title":"Pre-exposure prophylaxis: where HIV prevention and responsibility intersect.","volume":"25","author":"OHara","year":"2012","journal-title":"JAAPA"},{"issue":"6","key":"R41-3-20210130","doi-asserted-by":"crossref","first-page":"939","DOI":"10.2105\/AJPH.93.6.939","article-title":"Association of co-occurring psychosocial health problems and increased vulnerability to HIVAIDS among urban men who have sex with men.","volume":"93","author":"Stall","year":"2003","journal-title":"Am J Public Health"},{"issue":"11","key":"R42-3-20210130","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1037\/0003-066X.53.11.1199","article-title":"Toward a psychology of harm reduction.","volume":"53","author":"MacCoun","year":"1998","journal-title":"Am Psychol"},{"issue":"5996","key":"R43-3-20210130","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1193748","article-title":"Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.","volume":"329","author":"Abdool Karim","year":"2010","journal-title":"Science"}],"container-title":["Journal of the American Academy of Physician Assistants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.JAA.0000456567.37724.e0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T18:42:43Z","timestamp":1620931363000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01720610-201412000-00003"}},"subtitle":["Clinical and public health implications"],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/01.jaa.0000456567.37724.e0","relation":{},"ISSN":["1547-1896"],"issn-type":[{"value":"1547-1896","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]}}}